International Journal of Molecular Sciences · 2011 · 49 citations · 42 references
ManagementCorporate GovernanceOrganization StudiesCorporate DisclosureCorporate ReportingCorporate Social ResponsibilityCorporate Responsibility ReportingCorporate Social Responsibility ReportingCorporate TransparencyDisclosureOwnership StructureCorporate Ownership DisclosureCross-national Institutional DifferencesCsr DisclosureCsr ReportingSocial Expectations
Bioluminescence-based probes have long been used to quantify and visualize biological processes in vitro and in vivo. Over the past years, we have witnessed the trend of bioluminescence-driven optogenetic systems. Typically, bioluminescence emitted from coelenterazine-type luciferin-luciferase reactions activate light-sensitive proteins, which induce downstream events. The development of coelenterazine-type bioluminescence-induced photosensory domain-based probes has been applied in the imaging, sensing, and control of cellular activities, signaling pathways, and synthetic genetic circuits in vitro and in vivo. This strategy can not only shed light on the mechanisms of diseases, but also promote interrelated therapy development. Here, this review provides an overview of these optical probes for sensing and controlling biological processes, highlights their applications and optimizations, and discusses the possible future directions.
42
Corporate social and environmental reporting
Rob Gray, Reza Kouhy, Simon Lavers · Accounting Auditing & Accountability Journal · 1995 · 3.3K citations
Business, Accountancy, Accounting +11